The UK life sciences sector has attracted more than £3 billion of public and private investment over the past year, reinforcing the country’s position as a global leader in healthcare innovation. This investment is helping to create thousands of highly skilled jobs, support cutting-edge research, and accelerate the development of new medicines and treatments.
Alongside increased investment, improvements in the way clinical studies are set up are reducing delays, allowing research to begin sooner and giving eligible patients earlier access to innovative therapies. These initiatives aim to strengthen collaboration between the NHS, researchers and industry, ensuring that scientific discoveries can be translated into better patient care more quickly while supporting long-term economic growth across the UK.
